For example, multiple glutamatergic genes, as well as DRD2 (dopamine D2 receptor) were significant drivers at the CTP-11 meta-locus, in which genes reducing cognitive test performance are strongly associated with risk for schizophrenia (as well as many other forms of psychopathology). The gene discussed is DRD2; the disease is schizophrenia.